Seach Medical Group Ltd (SEMG) - Net Assets
Based on the latest financial reports, Seach Medical Group Ltd (SEMG) has net assets worth ILA103.11 Million ILA (≈ $276.45K USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA137.85 Million ≈ $369.57K USD) and total liabilities (ILA34.74 Million ≈ $93.13K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Seach Medical Group Ltd PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA103.11 Million |
| % of Total Assets | 74.8% |
| Annual Growth Rate | N/A |
| 5-Year Change | 4.14% |
| 10-Year Change | N/A |
| Growth Volatility | 34.55 |
Seach Medical Group Ltd - Net Assets Trend (2015–2025)
This chart illustrates how Seach Medical Group Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Seach Medical Group Ltd market capitalisation.
Annual Net Assets for Seach Medical Group Ltd (2015–2025)
The table below shows the annual net assets of Seach Medical Group Ltd from 2015 to 2025. Also explore SEMG year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ILA99.53 Million ≈ $266.84K |
-3.31% |
| 2024-12-31 | ILA102.94 Million ≈ $275.97K |
+15.67% |
| 2023-12-31 | ILA88.99 Million ≈ $238.58K |
-12.42% |
| 2022-12-31 | ILA101.62 Million ≈ $272.43K |
+6.32% |
| 2021-12-31 | ILA95.58 Million ≈ $256.24K |
+20.60% |
| 2020-12-31 | ILA79.25 Million ≈ $212.47K |
+69.48% |
| 2019-12-31 | ILA46.76 Million ≈ $125.36K |
+82.02% |
| 2018-12-31 | ILA25.69 Million ≈ $68.87K |
-18.12% |
| 2017-12-31 | ILA31.38 Million ≈ $84.12K |
+962.72% |
| 2016-12-31 | ILA-3.64 Million ≈ $-9.75K |
-904.70% |
| 2015-12-31 | ILA-362.00K ≈ $-970.51 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Seach Medical Group Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9507000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ILA10.56 Million | 11.85% |
| Common Stock | ILA70.73 Million | 79.31% |
| Other Comprehensive Income | ILA7.88 Million | 8.84% |
| Total Equity | ILA89.18 Million | 100.00% |
Seach Medical Group Ltd Competitors by Market Cap
The table below lists competitors of Seach Medical Group Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Compugates Holdings Bhd
KLSE:5037
|
$22.79 Million |
|
Renta Corporacion Real Estate SA
MC:REN
|
$22.79 Million |
|
SDT Uzay ve Savunma Teknolojileri A.S.
IS:SDTTR
|
$22.81 Million |
|
Saga Furs Oyj C
HE:SAGCV
|
$22.81 Million |
|
Music Broadcast Limited
NSE:RADIOCITY
|
$22.77 Million |
|
Allied Gaming & Entertainment Inc.
NASDAQ:AGAE
|
$22.76 Million |
|
YBM Net Inc
KQ:057030
|
$22.76 Million |
|
Golden Heaven Group Holdings Ltd. Ordinary Shares
NASDAQ:GDHG
|
$22.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Seach Medical Group Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 91,417,000 to 89,183,000, a change of -2,234,000 (-2.4%).
- Net income of 1,524,000 contributed positively to equity growth.
- Dividend payments of 3,967,000 reduced retained earnings.
- Other comprehensive income increased equity by 3,356,000.
- Other factors decreased equity by 3,147,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA1.52 Million | +1.71% |
| Dividends Paid | ILA3.97 Million | -4.45% |
| Other Comprehensive Income | ILA3.36 Million | +3.76% |
| Other Changes | ILA-3.15 Million | -3.53% |
| Total Change | ILA- | -2.44% |
Book Value vs Market Value Analysis
This analysis compares Seach Medical Group Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 96.57x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2015-12-31 | ILA-302.04 | ILA256.70 | x |
| 2016-12-31 | ILA-36.37 | ILA256.70 | x |
| 2017-12-31 | ILA1.10 | ILA256.70 | x |
| 2018-12-31 | ILA0.95 | ILA256.70 | x |
| 2019-12-31 | ILA1.77 | ILA256.70 | x |
| 2020-12-31 | ILA2.43 | ILA256.70 | x |
| 2021-12-31 | ILA2.55 | ILA256.70 | x |
| 2022-12-31 | ILA2.53 | ILA256.70 | x |
| 2023-12-31 | ILA2.28 | ILA256.70 | x |
| 2024-12-31 | ILA2.69 | ILA256.70 | x |
| 2025-12-31 | ILA2.66 | ILA256.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Seach Medical Group Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.71%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.97%
- • Asset Turnover: 1.13x
- • Equity Multiplier: 1.56x
- Recent ROE (1.71%) is below the historical average (1.88%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 0.00% | -267.27% | 0.66x | 0.00x | ILA-5.32 Million |
| 2016 | 0.00% | 17.61% | 4.11x | 0.00x | ILA1.94 Million |
| 2017 | 11.72% | 24.04% | 0.34x | 1.42x | ILA433.80K |
| 2018 | 36.90% | 43.21% | 0.55x | 1.54x | ILA5.84 Million |
| 2019 | -48.23% | -78.22% | 0.43x | 1.44x | ILA-27.23 Million |
| 2020 | 15.10% | 32.52% | 0.40x | 1.17x | ILA4.04 Million |
| 2021 | 6.22% | 7.94% | 0.52x | 1.49x | ILA-3.25 Million |
| 2022 | -3.96% | -2.54% | 0.83x | 1.88x | ILA-12.03 Million |
| 2023 | -13.56% | -6.99% | 1.15x | 1.69x | ILA-18.26 Million |
| 2024 | 14.79% | 7.88% | 1.17x | 1.61x | ILA4.38 Million |
| 2025 | 1.71% | 0.97% | 1.13x | 1.56x | ILA-7.39 Million |
Industry Comparison
This section compares Seach Medical Group Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $770,854,912
- Average return on equity (ROE) among peers: -25.99%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Seach Medical Group Ltd (SEMG) | ILA103.11 Million | 0.00% | 0.34x | $22.78 Million |
| Canzon Israel Ltd (CNZN) | $11.02 Million | -7.32% | 0.37x | $1.71 Million |
| Intercure (INCR) | $397.67 Million | -17.05% | 0.92x | $171.47 Million |
| Intelicanna Ltd (INTL) | $5.99 Billion | 17.47% | 6.78x | $6.41 Million |
| Kamada (KMDA) | $178.64 Million | 9.59% | 0.18x | $407.17 Million |
| Nextage Therapeutics Ltd (NXTG) | $-1.65 Million | 0.00% | 0.00x | $5.79 Million |
| Rekah Pharmaceutical Industry Ltd (REKA) | $58.85 Million | 10.97% | 3.54x | $34.21 Million |
| Teva Pharmaceutical Industries Ltd (TEVA) | $267.90 Million | 21.46% | 1.10x | $1.28 Billion |
| Together Startup Network Ltd (TGTR) | $-187.00K | 0.00% | 0.00x | $7.95 Million |
| Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) | $33.04 Million | -269.00% | 1.32x | $28.21 Million |
About Seach Medical Group Ltd
Seach Medical Group Ltd manufactures and sells medicinal cannabis products worldwide. The company provides cannabis oil and medical cannabis inflorescence products. Seach Medical Group Ltd was incorporated in 1987 and is based in Ramat Gan, Israel.